Atossa Therapeutics News

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Finn Jonathan

Apr 11 16:06 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cigler Tessa

Mar 14 20:40 ET

Atossa Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cigler Tessa

Mar 14 20:30 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEAVER GREGORY L

Nov 17, 2023 16:01 ET

Atossa Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Finn Jonathan

Nov 15, 2023 17:03 ET

Atossa Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Finn Jonathan

Nov 15, 2023 16:15 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Finn Jonathan

Nov 15, 2023 16:05 ET

Atossa Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Rees Heather

Oct 16, 2023 16:00 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEAVER GREGORY L

Jun 20, 2023 20:15 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEAVER GREGORY L

Jun 5, 2023 09:00 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WEAVER GREGORY L

May 5, 2023 19:36 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Remmel H. Lawrence

May 5, 2023 19:36 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Steinhart Richard I

May 5, 2023 19:35 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chen Shu-Chih

May 5, 2023 19:35 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Galli Stephen J

May 5, 2023 19:35 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer QUAY STEVEN C

Mar 6, 2023 16:11 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Guse Kyle

Mar 6, 2023 16:10 ET

Atossa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.50%)

Feb 9, 2023 11:07 ET

Atossa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(2.8%)

Jul 8, 2022 16:57 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities

May 16, 2022 18:24 ET